FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY HIP LINER

MDR report key: 4091613 · Received September 16, 2014

Report

Report Number
1818910-2014-28138
Event Type
Injury
Date Received
September 16, 2014
Date of Event
September 8, 2014
Report Date
September 8, 2014
Manufacturer
1818910 DEPUY ORTHOPAEDICS, INC.
Product Code
KWA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENT WAS REVISED BECAUSE OF OSTEOLYSIS, POLY WEAR, AND FRACTURED LINER. (B)(4). THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE AS THE PRODUCT AND LOT CODE REQUIRED WAS NOT PROVIDED. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. NO ADDITIONAL INFORMATION WAS OBTAINED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITHOUT DEVICE EXAMINATION. HOWEVER ALTHOUGH NOT RETURNED, IT WOULD NOT BE UNREASONABLE TO FIND POLY MATERIAL WEAR AFTER THE LENGTH OF TIME REPORTED AS IMPLANTED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

THE PATIENT WAS REVISED BECAUSE OF OSTEOLYSIS, POLY WEAR, AND FRACTURED LINER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
570995 UNKNOWN DEPUY HIP LINER HIP ACETABULAR INSERT/LINER KWA 1818910 DEPUY ORTHOPAEDICS, INC. UNK

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention